Related Experiment Video

Updated: May 28, 2026

Isolation, Expansion, and Adipogenic Induction of CD34+CD31+ Endothelial Cells from Human Omental and Subcutaneous Adipose Tissue
10:28

Isolation, Expansion, and Adipogenic Induction of CD34+CD31+ Endothelial Cells from Human Omental and Subcutaneous Adipose Tissue

Published on: July 17, 2018

Adiponectin as a marker of complications in type I diabetes

Nevin Mohamed Mamdouh Habeeb1, Omneya Ibrahim Youssef, Azza Abdel Rahman Saab

  • 1Department of Pediatrics, Ain Shams University, Cairo, Egypt.

Indian Pediatrics
|October 14, 2011
PubMed

Insights

Elevated adiponectin levels in children with type 1 diabetes are linked to poor glucose control and complications like nephropathy. This finding highlights adiponectin as a potential biomarker for disease progression.

Area of Science:

  • Pediatric Endocrinology
  • Metabolic Disorders
  • Diabetes Complications

Background:

  • Type 1 diabetes (T1D) in children and adolescents requires monitoring for long-term complications.
  • Adiponectin, an adipokine, plays a role in glucose metabolism and inflammation.
  • Understanding adiponectin's role in T1D complications is crucial for early intervention.

Purpose of the Study:

  • To investigate serum adiponectin levels in pediatric patients with T1D.
  • To determine the association between adiponectin levels and long-term diabetic complications.
  • To explore the relationship between adiponectin, glycemic control, and renal function.

Main Methods:

  • A cross-sectional study was conducted at a tertiary referral hospital.
  • Participants included 30 children and adolescents with T1D (complicated and non-complicated) and 10 healthy controls.
  • Assessments included anthropometry, neurological exam, funduscopy, echocardiography, and laboratory assays (HbA1c, creatinine, urinary protein, serum adiponectin).

Main Results:

  • Serum adiponectin was significantly higher in complicated T1D patients (10.3 ± 5.9 pg/dL) compared to controls (6.5 ± 3.7 pg/dL).
  • Adiponectin levels correlated positively with HbA1c and creatinine.
  • Patients with nephropathy exhibited markedly elevated adiponectin levels (15.7 ± 3.7 pg/dL).

Conclusions:

  • Elevated serum adiponectin in pediatric T1D suggests poor glycemic control.
  • Increased adiponectin is indicative of developing diabetic complications, particularly nephropathy.
  • Adiponectin may serve as a valuable biomarker for monitoring T1D progression and complications in children and adolescents.
Abstract

More Related Videos

A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes05:18

A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes

Published on: February 17, 2023

Related Concept Videos

Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.